Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA. PARAMEDIC2 was just published and is the largest randomized double-blind, placebo-controlled trial to evaluate the use of epinephrine in OHCA. Dr. Rory Spiegel joins...
NIPPV is frequently used in the management of critically ill patients presenting with an acute COPD exacerbation, as NIPPV decreases the rates of intubation...
Resuscitations are often chaotic events. How we perform under pressure can make the difference between life and death. In this podcast we discuss a...
Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic...